An NYT story blamed leftists for obstructing psychedelic therapy… truth is…
Without the efforts of this “small band of anticapitalist activists,” the authors argue, Lykos Therapeutics’ “$250 million investment” in MDMA-AT may have paid off by being the first psychedelic therapy to get federal approval – potentially establishing the company as a multibillion-dollar enterprise.
As a journalist who has followed the psychedelics movement for years and attended hearings during the FDA approval process to write about them… the story was stunning. It was largely divorced from the events as I witnessed them, misleading in crucial ways… but what the story lacks in fully recounting why Lykos’ application tanked, it makes up for in fostering outrage, scapegoating a fringe group, and establishing a useful narrative… FDA’s decision.
Original Article (Slate):
An NYT story blamed leftists for obstructing psychedelic therapy. The truth is much more infuriating.
Artwork Fair Use: Public Domain
Recent Comments